GB9801363D0 - Novel dosage form - Google Patents

Novel dosage form

Info

Publication number
GB9801363D0
GB9801363D0 GBGB9801363.4A GB9801363A GB9801363D0 GB 9801363 D0 GB9801363 D0 GB 9801363D0 GB 9801363 A GB9801363 A GB 9801363A GB 9801363 D0 GB9801363 D0 GB 9801363D0
Authority
GB
United Kingdom
Prior art keywords
dosage form
novel dosage
novel
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9801363.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyowa Kirin Services Ltd
Original Assignee
Danbiosyst UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Danbiosyst UK Ltd filed Critical Danbiosyst UK Ltd
Priority to GBGB9801363.4A priority Critical patent/GB9801363D0/en
Publication of GB9801363D0 publication Critical patent/GB9801363D0/en
Priority to EP99901758A priority patent/EP1059918A1/en
Priority to JP2000528272A priority patent/JP2002501016A/ja
Priority to CA002318257A priority patent/CA2318257A1/en
Priority to AU21760/99A priority patent/AU2176099A/en
Priority to PCT/GB1999/000193 priority patent/WO1999037290A1/en
Priority to ZA9900454A priority patent/ZA99454B/xx
Priority to ARP990100264A priority patent/AR014467A1/es
Priority to NO20003640A priority patent/NO20003640L/no
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
GBGB9801363.4A 1998-01-22 1998-01-22 Novel dosage form Ceased GB9801363D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form
EP99901758A EP1059918A1 (en) 1998-01-22 1999-01-20 Novel dosage form
JP2000528272A JP2002501016A (ja) 1998-01-22 1999-01-20 新しい投薬形態
CA002318257A CA2318257A1 (en) 1998-01-22 1999-01-20 Novel dosage form
AU21760/99A AU2176099A (en) 1998-01-22 1999-01-20 Novel dosage form
PCT/GB1999/000193 WO1999037290A1 (en) 1998-01-22 1999-01-20 Novel dosage form
ZA9900454A ZA99454B (en) 1998-01-22 1999-01-21 Novel dosage form.
ARP990100264A AR014467A1 (es) 1998-01-22 1999-01-22 Unidad de dosis farmaceutica oralmente administrable de un tamano superior a 7 mm que comprende una droga y un recubrimiento externo, un metodo paraseparar una unidad de dosis farmaceutica oralmente administrable a partir de un alimento co-administrado y el uso de una droga y un material de recubrim
NO20003640A NO20003640L (no) 1998-01-22 2000-07-14 Ny doseringsform

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9801363.4A GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form

Publications (1)

Publication Number Publication Date
GB9801363D0 true GB9801363D0 (en) 1998-03-18

Family

ID=10825713

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9801363.4A Ceased GB9801363D0 (en) 1998-01-22 1998-01-22 Novel dosage form

Country Status (9)

Country Link
EP (1) EP1059918A1 (no)
JP (1) JP2002501016A (no)
AR (1) AR014467A1 (no)
AU (1) AU2176099A (no)
CA (1) CA2318257A1 (no)
GB (1) GB9801363D0 (no)
NO (1) NO20003640L (no)
WO (1) WO1999037290A1 (no)
ZA (1) ZA99454B (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9910773D0 (en) * 1999-05-11 1999-07-07 West Pharm Serv Drug Res Ltd Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
WO2006020009A1 (en) * 2004-07-23 2006-02-23 The Procter & Gamble Company Solid oral dosage form of a bisphosphonate containing a chelating agent
US8912908B2 (en) 2005-04-28 2014-12-16 Proteus Digital Health, Inc. Communication system with remote activation
US9198608B2 (en) 2005-04-28 2015-12-01 Proteus Digital Health, Inc. Communication system incorporated in a container
US8836513B2 (en) 2006-04-28 2014-09-16 Proteus Digital Health, Inc. Communication system incorporated in an ingestible product
EP2671508B1 (en) 2005-04-28 2020-09-16 Proteus Digital Health, Inc. Pharma-informatics system
US8802183B2 (en) 2005-04-28 2014-08-12 Proteus Digital Health, Inc. Communication system with enhanced partial power source and method of manufacturing same
JP2009544338A (ja) 2006-05-02 2009-12-17 プロテウス バイオメディカル インコーポレイテッド 患者に合わせてカスタマイズした治療レジメン
SG175681A1 (en) 2006-10-25 2011-11-28 Proteus Biomedical Inc Controlled activation ingestible identifier
WO2008063626A2 (en) 2006-11-20 2008-05-29 Proteus Biomedical, Inc. Active signal processing personal health signal receivers
WO2008095183A2 (en) 2007-02-01 2008-08-07 Proteus Biomedical, Inc. Ingestible event marker systems
KR101528748B1 (ko) 2007-02-14 2015-06-15 프로테우스 디지털 헬스, 인코포레이티드 고 표면적 전극을 갖는 체내 전원
US8932221B2 (en) 2007-03-09 2015-01-13 Proteus Digital Health, Inc. In-body device having a multi-directional transmitter
US9270025B2 (en) 2007-03-09 2016-02-23 Proteus Digital Health, Inc. In-body device having deployable antenna
US8115618B2 (en) 2007-05-24 2012-02-14 Proteus Biomedical, Inc. RFID antenna for in-body device
EP4011289A1 (en) 2007-09-25 2022-06-15 Otsuka Pharmaceutical Co., Ltd. In-body device with virtual dipole signal amplification
CA2717809A1 (en) 2007-11-27 2009-06-04 Proteus Biomedical, Inc. Transbody communication systems employing communication channels
WO2009111664A2 (en) 2008-03-05 2009-09-11 Proteus Biomedical, Inc. Multi-mode communication ingestible event markers and systems, and methods of using the same
KR101615128B1 (ko) 2008-07-08 2016-04-26 프로테우스 디지털 헬스, 인코포레이티드 섭취 가능한 이벤트 마커 데이터 프레임워크
CN102176862B (zh) 2008-08-13 2014-10-22 普罗透斯数字保健公司 可摄入电路
EP2385781A4 (en) 2009-01-06 2014-11-05 Proteus Digital Health Inc BIOLOGICAL FEEDBACK RELATED TO INGESTION AND PERSONALIZED MEDICAL TREATMENT METHOD AND SYSTEM
WO2010111403A2 (en) 2009-03-25 2010-09-30 Proteus Biomedical, Inc. Probablistic pharmacokinetic and pharmacodynamic modeling
BR122013009559A2 (pt) 2009-04-28 2019-08-06 Proteus Digital Health, Inc. Marcadores de evento de ingerível altamente confiável e métodos para usar os mesmos
US9149423B2 (en) 2009-05-12 2015-10-06 Proteus Digital Health, Inc. Ingestible event markers comprising an ingestible component
TWI517050B (zh) 2009-11-04 2016-01-11 普羅托斯數位健康公司 供應鏈管理之系統
MX2012011693A (es) 2010-04-07 2013-02-15 Proteus Digital Health Inc Dispositivo ingerible miniatura.
TWI557672B (zh) 2010-05-19 2016-11-11 波提亞斯數位康健公司 用於從製造商跟蹤藥物直到患者之電腦系統及電腦實施之方法、用於確認將藥物給予患者的設備及方法、患者介面裝置
JP2014504902A (ja) 2010-11-22 2014-02-27 プロテウス デジタル ヘルス， インコーポレイテッド 医薬品を有する摂取可能なデバイス
WO2015112603A1 (en) 2014-01-21 2015-07-30 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
US9756874B2 (en) 2011-07-11 2017-09-12 Proteus Digital Health, Inc. Masticable ingestible product and communication system therefor
AU2012284125A1 (en) 2011-07-21 2014-02-06 Proteus Digital Health, Inc. Mobile communication device, system, and method
US9235683B2 (en) 2011-11-09 2016-01-12 Proteus Digital Health, Inc. Apparatus, system, and method for managing adherence to a regimen
CA2897198A1 (en) 2012-07-23 2014-01-30 Proteus Digital Health, Inc. Techniques for manufacturing ingestible event markers comprising an ingestible component
KR101565013B1 (ko) 2012-10-18 2015-11-02 프로테우스 디지털 헬스, 인코포레이티드 통신 디바이스를 위한 전원에서 전력 소비 및 브로드캐스트 전력을 적응적으로 최적화시키는 장치, 시스템 및 방법
TWI659994B (zh) 2013-01-29 2019-05-21 美商普羅托斯數位健康公司 高度可膨脹之聚合型薄膜及包含彼之組成物
WO2014144738A1 (en) 2013-03-15 2014-09-18 Proteus Digital Health, Inc. Metal detector apparatus, system, and method
EP3005281A4 (en) 2013-06-04 2017-06-28 Proteus Digital Health, Inc. System, apparatus and methods for data collection and assessing outcomes
US9796576B2 (en) 2013-08-30 2017-10-24 Proteus Digital Health, Inc. Container with electronically controlled interlock
US10084880B2 (en) 2013-11-04 2018-09-25 Proteus Digital Health, Inc. Social media networking based on physiologic information
US11051543B2 (en) 2015-07-21 2021-07-06 Otsuka Pharmaceutical Co. Ltd. Alginate on adhesive bilayer laminate film
SG10202101937PA (en) 2016-07-22 2021-03-30 Proteus Digital Health Inc Electromagnetic sensing and detection of ingestible event markers
EP3531901A4 (en) 2016-10-26 2021-01-27 Proteus Digital Health, Inc. CAPSULE PREPARATION PROCESSES WITH INGERABLE EVENT MARKERS
US11458104B1 (en) * 2018-06-21 2022-10-04 Mission Pharmacal Company Enteric coated tiopronin tablet
CN109453166B (zh) * 2018-10-16 2021-03-12 丹诺医药(苏州）有限公司 一种利福霉素-喹嗪酮偶联分子的固体分散体及其应用
CN110613697A (zh) * 2019-10-30 2019-12-27 长春迪瑞制药有限公司 一种头孢氨苄胶囊及制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4786508A (en) * 1986-05-30 1988-11-22 Warner-Lambert Company Coated dosage forms
FR2618331B1 (fr) * 1987-07-23 1991-10-04 Synthelabo Compositions pharmaceutiques utiles pour le traitement de l'uremie
NZ228557A (en) * 1988-04-05 1990-11-27 Kyowa Hakko Kogyo Kk Coating agent for delaying the release of active agents to be administered per os to ruminants, and veterinary compositions

Also Published As

Publication number Publication date
CA2318257A1 (en) 1999-07-29
AR014467A1 (es) 2001-02-28
AU2176099A (en) 1999-08-09
JP2002501016A (ja) 2002-01-15
WO1999037290A1 (en) 1999-07-29
EP1059918A1 (en) 2000-12-20
NO20003640L (no) 2000-09-12
ZA99454B (en) 2000-10-23
NO20003640D0 (no) 2000-07-14

Similar Documents

Publication Publication Date Title
GB9801363D0 (en) Novel dosage form
GB9817118D0 (en) Pharmaceutical compounds
HK1033649A1 (en) Extended release dosage form
PL341642A1 (en) Novel macrolydes
GB9817623D0 (en) Pharmaceutical compounds
PL343627A1 (en) Medicinal compositions
SG77244A1 (en) Nefazodone dosage form
PT1466615E (pt) Composição farmacêutica
GB9810886D0 (en) Pharmaceutical compounds
PL343769A1 (en) Pharmaceutical composition
GB9818591D0 (en) Pharmaceutical composition
EP1068213A4 (en) SILOXANES WITH AMINO-ORGANIC FUNCTIONAL GROUP
GB9800750D0 (en) Pharmaceutical compound
GB9823847D0 (en) Pharmaceutical compounds
GB9823845D0 (en) Pharmaceutical compounds
HK1044117B (zh) 藥物組合物
GB9808665D0 (en) Therapeutic compounds
PL338781A1 (en) Dosage form
GB9824897D0 (en) Therapeutic compounds
GB9817197D0 (en) Pharmaceutical compounds
GB9827865D0 (en) Medicament
TW407677U (en) Form
HU9800078D0 (en) Pharmaceutical composition
GB9718683D0 (en) Novel dosage form
GB9808667D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)